论文部分内容阅读
老年急性髓系白血病化疗缓解率低,对化疗耐受性差,化疗相关死亡明显高于年轻患者,因此,探索老年急性髓系白血病的化疗方案的组成和剂量至关重要。我科2006年1月～2009年1月用米托蒽醌(M)、阿糖胞苷(A)联合粒细胞集落刺激因子(G-CSF),即MAG方案治疗老年急性髓系白血病(AML)12例,
Elderly acute myeloid leukemia with low response rate of chemotherapy, poor chemotherapy, chemotherapy-related mortality was significantly higher than younger patients, therefore, to explore the composition and dose of chemotherapy in elderly patients with acute myeloid leukemia is essential. Our department from January 2006 to January 2009 with mitoxantrone (M), cytarabine (A) combined with granulocyte-colony stimulating factor (G-CSF), the MAG program for the treatment of Acute Myeloid Leukemia (AML ) 12 cases,